<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.4"?>
<!-- generated-on="2026-05-21T05:02:53+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.4" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://news.medxy.ai/intraoperative-intravitreal-bevacizumab-extended-trabeculectomy-survival-to-3-years-in-a-randomized-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T17:45:37-07:00</news:publication_date><news:title>Intraoperative Intravitreal Bevacizumab Extended Trabeculectomy Survival to 3 Years in a Randomized Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e9%a0%ad%e9%a0%b8%e9%83%a8%e3%81%8c%e3%82%93%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e5%85%8d%e7%96%ab%e7%99%82%e6%b3%95%e5%8f%8d%e5%bf%9c%e3%81%a8bmi%e3%83%bb%e6%a0%84%e9%a4%8a%e7%8a%b6%e6%85%8b/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T13:55:43-07:00</news:publication_date><news:title>頭頸部がんにおける免疫療法反応とBMI・栄養状態の関連</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/chi-so-khoi-co-the-va-tinh-trang-dinh-duong-voi-dap-ung-mien-dich-trong-ung-thu-dau-co/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-20T13:54:30-07:00</news:publication_date><news:title>Chỉ số khối cơ thể và tình trạng dinh dưỡng với đáp ứng miễn dịch trong ung thư đầu cổ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/body-mass-index-and-nutritional-status-with-immunotherapy-response-in-head-and-neck-cancer/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T13:52:47-07:00</news:publication_date><news:title>Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/%e6%97%a9%e6%9c%9f%e7%8e%af%e5%92%bd%e8%82%8c%e5%b9%b2%e9%a2%84%e5%8f%af%e8%83%bd%e6%94%b9%e5%96%84%e7%a5%9e%e7%bb%8f%e6%8d%9f%e4%bc%a4%e5%90%8e%e4%b8%8a%e9%a3%9f%e7%ae%a1%e6%8b%ac%e7%ba%a6%e8%82%8c/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-05-20T13:09:59-07:00</news:publication_date><news:title>早期环咽肌干预可能改善神经损伤后上食管括约肌开放缺失患者的经口进食</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e6%97%a9%e6%9c%9f%e7%92%b0%e5%92%bd%e7%ad%8b%e6%89%8b%e8%a1%93%e4%bb%8b%e5%85%a5%e5%8f%af%e8%83%bd%e6%94%b9%e5%96%84%e7%a5%9e%e7%b5%8c%e9%9a%9c%e5%ae%b3%e5%be%8c%e3%81%ae%e4%b8%8a%e9%83%a8%e9%a3%9f/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T13:07:55-07:00</news:publication_date><news:title>早期環咽筋手術介入可能改善神経障害後の上部食道括約筋開放不全の経口摂取</news:title></news:news></url>
<url><loc>https://news.medxy.ai/earlier-cricopharyngeal-intervention-may-improve-oral-intake-in-absent-ues-opening-after-neurological-injury/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T13:03:10-07:00</news:publication_date><news:title>Earlier Cricopharyngeal Intervention May Improve Oral Intake in Absent UES Opening After Neurological Injury</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e6%b2%bb%e7%99%82%e3%81%b8%e3%81%ae%e4%b8%8d%e5%9d%87%e7%ad%89%e3%81%aa%e9%81%93-%e5%9c%b0%e5%9f%9f%e3%80%81%e8%be%b2%e6%9d%91%e6%80%a7%e3%80%81%e3%81%8a%e3%82%88%e3%81%b3%e5%89%a5%e5%a4%ba%e3%81%8c/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T13:01:30-07:00</news:publication_date><news:title>治療への不均等な道: 地域、農村性、および剥夺が重症外傷患者の認定外傷センターや運送に与える影響</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/con-duong-cham-soc-khong-dong-deu-cach-khu-vuc-nong-thon-va-su-tuoc-quyen-anh-huong-den-viec-van-chuyen-den-cac-trung-tam-chan-thuong-da-xac-minh-cho-nhung-benh-nhan-bi-chan-thuong-nghiem-trong/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-20T12:59:55-07:00</news:publication_date><news:title>Con đường chăm sóc không đồng đều: Cách khu vực, nông thôn và sự tước quyền ảnh hưởng đến việc vận chuyển đến các trung tâm chấn thương đã xác minh cho những bệnh nhân bị chấn thương nghiêm trọng</news:title></news:news></url>
<url><loc>https://news.medxy.ai/unequal-paths-to-care-how-region-rurality-and-deprivation-shape-transport-to-verified-trauma-centers-among-the-critically-injured/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T12:57:42-07:00</news:publication_date><news:title>Unequal Paths to Care: How Region, Rurality, and Deprivation Shape Transport to Verified Trauma Centers Among the Critically Injured</news:title></news:news></url>
<url><loc>https://news.medxy.ai/higher-fidelity-enhanced-recovery-shortened-stay-and-reduced-complications-in-children-undergoing-gi-surgery-even-though-the-overall-trial-was-neutral/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T12:43:30-07:00</news:publication_date><news:title>Higher-Fidelity Enhanced Recovery Shortened Stay and Reduced Complications in Children Undergoing GI Surgery, Even Though the Overall Trial Was Neutral</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/abrupt2%e8%a9%a6%e9%a8%93%ef%bc%9a5%e3%82%a2%e3%83%ab%e3%83%96%e3%83%9f%e3%83%b3%e3%81%8c%e5%a4%a7%e8%a6%8f%e6%a8%a1%e3%82%84%e3%81%91%e3%81%a9%e8%98%87%e7%94%9f%e6%99%82%e3%81%ae%e8%bc%b8%e6%b6%b2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T12:25:40-07:00</news:publication_date><news:title>ABRUPT2試験：5%アルブミンが大規模やけど蘇生時の輸液量を減少させた</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/thu-nghiem-abrupt2-5-albumin-giam-yeu-cau-dung-dich-trong-phuc-hoi-chan-thuong-nghiem-trong/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-20T12:24:10-07:00</news:publication_date><news:title>Thử nghiệm ABRUPT2: 5% Albumin Giảm Yêu Cầu Dung Dịch trong Phục Hồi Chấn Thương Nghiêm Trọng</news:title></news:news></url>
<url><loc>https://news.medxy.ai/abrupt2-trial-5-albumin-reduced-fluid-requirements-in-major-burn-resuscitation/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T12:22:10-07:00</news:publication_date><news:title>ABRUPT2 Trial: 5% Albumin Reduced Fluid Requirements in Major Burn Resuscitation</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e3%82%a2%e3%83%a1%e3%83%aa%e3%82%ab%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8bfigo-2014%e5%b9%b4iii-iva%e6%9c%9f%e5%ad%90%e5%ae%ae%e9%a0%b8%e3%81%8c%e3%82%93%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e3%83%9a/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T11:59:54-07:00</news:publication_date><news:title>アメリカにおけるFIGO 2014年III-IVA期子宮頸がんに対するペムブロリズマブの費用対効果</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/hieu-qua-kinh-te-cua-pembrolizumab-trong-dieu-tri-ung-thu-co-tu-cung-giai-doan-iii-iva-theo-figo-2014-tai-hoa-ky/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-20T11:58:17-07:00</news:publication_date><news:title>Hiệu quả kinh tế của Pembrolizumab trong điều trị ung thư cổ tử cung giai đoạn III-IVA theo FIGO 2014 tại Hoa Kỳ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/cost-effectiveness-of-pembrolizumab-for-figo-2014-stage-iii-iva-cervical-cancer-in-the-united-states/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T11:56:37-07:00</news:publication_date><news:title>Cost-effectiveness of Pembrolizumab for FIGO 2014 Stage III-IVA Cervical Cancer in the United States</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e5%a4%9a%e5%9b%8a%e5%8d%b5%e5%b7%a2%e7%bb%bc%e5%90%88%e5%be%81%e4%b8%ad%e5%ad%90%e5%ae%ab%e5%86%85%e8%86%9c%e5%8a%9f%e8%83%bd%e9%9a%9c%e7%a2%8d%e7%9a%84%e5%be%ae%e7%94%9f%e7%89%a9%e5%92%8c%e4%bb%a3/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T11:53:42-07:00</news:publication_date><news:title>多囊卵巢综合征中子宫内膜功能障碍的微生物和代谢相关因素：一项转化研究</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/cac-yeu-to-vi-sinh-va-chuyen-hoa-lien-quan-den-roi-loan-noi-mac-tu-cung-trong-hoi-chung-buong-trung-da-nang-mot-nghien-cuu-dich-te-hoc/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-20T11:52:26-07:00</news:publication_date><news:title>Các yếu tố vi sinh và chuyển hóa liên quan đến rối loạn nội mạc tử cung trong hội chứng buồng trứng đa nang: Một nghiên cứu dịch tễ học</news:title></news:news></url>
<url><loc>https://news.medxy.ai/microbial-and-metabolic-correlates-of-endometrial-dysfunction-in-polycystic-ovary-syndrome-a-translational-study/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T11:50:04-07:00</news:publication_date><news:title>Microbial and Metabolic Correlates of Endometrial Dysfunction in Polycystic Ovary Syndrome: A Translational Study</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e5%88%86%e5%a8%a9%e3%81%a8%e5%b8%9d%e7%8e%8b%e5%88%87%e9%96%8b%e5%be%8c%e3%81%ae%e8%a9%a6%e9%a8%93%e5%8a%b4%e5%83%8d%e3%81%ae%e4%bd%bf%e7%94%a8%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e4%ba%ba%e7%a8%ae/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T11:31:56-07:00</news:publication_date><news:title>分娩と帝王切開後の試験労働の使用における人種的分離の影響</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/moi-lien-he-giua-phan-biet-chung-toc-trong-dich-vu-sinh-no-va-viec-su-dung-thu-nghiem-chuyen-da-sau-mo-lay-thai-va-sinh-thuong-sau-mo-lay-thai/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-20T11:30:46-07:00</news:publication_date><news:title>Mối liên hệ giữa phân biệt chủng tộc trong dịch vụ sinh nở và việc sử dụng thử nghiệm chuyển dạ sau mổ lấy thai và sinh thường sau mổ lấy thai</news:title></news:news></url>
<url><loc>https://news.medxy.ai/association-between-racial-segregation-of-labor-and-delivery-services-and-use-of-trial-of-labor-and-vaginal-birth-after-cesarean/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T11:29:05-07:00</news:publication_date><news:title>Association Between Racial Segregation of Labor and Delivery Services and Use of Trial of Labor and Vaginal Birth After Cesarean</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e7%b3%96%e5%b0%bf%e7%97%85%e3%80%81%e7%94%b7%e6%80%a7%e6%80%a7%e5%88%a5%e3%80%81%e4%bd%8ehbsag%e3%80%81hdv-rna%e3%80%81alt%e4%ba%88%e6%b8%ac%e6%85%a2%e6%80%a7d%e5%9e%8b%e8%82%9d%e7%82%8e%e8%87%aa/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T11:25:38-07:00</news:publication_date><news:title>糖尿病、男性性別、低HBsAg、HDV RNA、ALT予測慢性D型肝炎自発的HDV抑制</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/dai-thao-duong-gioi-tinh-nam-va-nong-do-hbsag-hdv-rna-alt-thap-du-doan-su-uc-che-tu-nhien-cua-hdv-trong-viem-gan-d-man-tinh/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-20T11:24:23-07:00</news:publication_date><news:title>Đái tháo đường, giới tính nam và nồng độ HBsAg, HDV RNA, ALT thấp dự đoán sự ức chế tự nhiên của HDV trong viêm gan D mạn tính</news:title></news:news></url>
<url><loc>https://news.medxy.ai/diabetes-male-sex-and-low-hbsag-hdv-rna-and-alt-predict-spontaneous-hdv-suppression-in-chronic-hepatitis-d/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T11:22:40-07:00</news:publication_date><news:title>Diabetes, Male Sex, and Low HBsAg, HDV RNA, and ALT Predict Spontaneous HDV Suppression in Chronic Hepatitis D</news:title></news:news></url>
<url><loc>https://news.medxy.ai/targeting-mlck1-may-separate-immune-checkpoint-inhibitor-colitis-from-antitumour-benefit/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T11:03:28-07:00</news:publication_date><news:title>Targeting MLCK1 May Separate Immune Checkpoint Inhibitor Colitis From Antitumour Benefit</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e8%84%b3%e5%8d%92%e4%b8%ad%e5%be%8c%e3%81%ae%e9%95%b7%e6%9c%9f%e8%aa%8d%e7%9f%a5%e5%9b%9e%e5%be%a9%ef%bc%9a%e3%82%aa%e3%83%83%e3%82%af%e3%82%b9%e3%83%95%e3%82%a9%e3%83%bc%e3%83%89%e8%aa%8d%e7%9f%a5/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T11:01:49-07:00</news:publication_date><news:title>脳卒中後の長期認知回復：オックスフォード認知スクリーニングの示すもの</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/phuc-hoi-nhan-thuc-dai-han-sau-dot-quy-dieu-ma-bang-danh-gia-nhan-thuc-oxford-tiet-lo/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-20T11:00:19-07:00</news:publication_date><news:title>Phục hồi nhận thức dài hạn sau đột quỵ: Điều mà Bảng đánh giá nhận thức Oxford tiết lộ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/long-term-cognitive-recovery-after-stroke-what-the-oxford-cognitive-screen-reveals/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T10:58:18-07:00</news:publication_date><news:title>Long-Term Cognitive Recovery After Stroke: What the Oxford Cognitive Screen Reveals</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e6%97%a9%e6%9c%9f%e3%83%91%e3%83%bc%e3%82%ad%e3%83%b3%e3%82%bd%e3%83%b3%e7%97%85%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e5%ae%9a%e7%94%a8%e9%87%8f%e3%82%bf%e3%83%90%e3%83%91%e3%83%89%e3%83%b3%ef%bc%9a/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T10:33:37-07:00</news:publication_date><news:title>早期パーキンソン病に対する定用量タバパドン：無作為化臨床試験</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/tavapadon-lieu-co-dinh-cho-benh-parkinson-som-mot-thu-nghiem-lam-sang-ngau-nhien/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-20T10:32:06-07:00</news:publication_date><news:title>Tavapadon liều cố định cho bệnh Parkinson sớm: Một thử nghiệm lâm sàng ngẫu nhiên</news:title></news:news></url>
<url><loc>https://news.medxy.ai/fixed-dose-tavapadon-for-early-parkinson-disease-a-randomized-clinical-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T10:30:37-07:00</news:publication_date><news:title>Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e7%94%b2%e7%8a%b6%e8%85%ba%e5%88%87%e9%99%a4%e8%a1%93%e5%be%8c%e3%81%ae%e7%96%b2%e5%8a%b4-%e6%82%a3%e8%80%85%e3%81%8c%e5%ae%9f%e9%9a%9b%e3%81%ab%e7%b5%8c%e9%a8%93%e3%81%99%e3%82%8b%e3%81%93%e3%81%a8/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T10:28:50-07:00</news:publication_date><news:title>甲状腺切除術後の疲労: 患者が実際に経験すること</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/%e7%94%b2%e7%8a%b6%e8%85%ba%e5%88%87%e9%99%a4%e6%9c%af%e5%90%8e%e7%96%b2%e5%8a%b3%ef%bc%9a%e6%82%a3%e8%80%85%e7%9a%84%e5%ae%9e%e9%99%85%e4%bd%93%e9%aa%8c/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-05-20T10:27:34-07:00</news:publication_date><news:title>甲状腺切除术后疲劳：患者的实际体验</news:title></news:news></url>
<url><loc>https://news.medxy.ai/fatigue-after-thyroidectomy-what-patients-actually-experience/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T10:26:27-07:00</news:publication_date><news:title>Fatigue After Thyroidectomy: What Patients Actually Experience</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/%e8%83%b0%e5%b2%9b%ce%b2%e7%bb%86%e8%83%9e%e5%8d%8f%e5%90%8c%e4%bf%9d%e6%8a%a4%ef%bc%9aglp1-e2%e4%b8%8e%e4%bd%8e%e5%89%82%e9%87%8f%e6%8a%97cd3%e8%81%94%e5%90%88%e7%96%97%e6%b3%95%e5%9c%a8%e8%87%aa/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-05-20T10:20:50-07:00</news:publication_date><news:title>胰岛β细胞协同保护：GLP1-E2与低剂量抗CD3联合疗法在自身免疫性糖尿病中的应用</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e8%86%b5%ce%b2%e7%b4%b0%e8%83%9e%e3%81%ae%e7%9b%b8%e4%b9%97%e4%bf%9d%e8%ad%b7%ef%bc%9aglp1-e2%e3%81%a8%e4%bd%8e%e7%94%a8%e9%87%8f%e6%8a%97cd3%e4%bd%b5%e7%94%a8%e7%99%82%e6%b3%95%e3%81%ab%e3%82%88/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-20T10:19:48-07:00</news:publication_date><news:title>膵β細胞の相乗保護：GLP1-E2と低用量抗CD3併用療法による自己免疫性糖尿病の治療</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/bao-ve-phoi-hop-te-bao-%ce%b2-tuy-lieu-phap-ket-hop-glp1-e2-va-anti-cd3-lieu-thap-trong-dai-thao-duong-tu-mien/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-20T10:18:17-07:00</news:publication_date><news:title>Bảo vệ phối hợp tế bào β tụy: liệu pháp kết hợp GLP1-E2 và anti-CD3 liều thấp trong đái tháo đường tự miễn</news:title></news:news></url>
<url><loc>https://news.medxy.ai/synergistic-protection-of-pancreatic-beta-cells-glp1-e2-and-low-dose-anti-cd3-combination-therapy-in-autoimmune-diabetes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-20T10:15:42-07:00</news:publication_date><news:title>Synergistic Protection of Pancreatic Beta Cells: GLP1-E2 and Low-Dose Anti-CD3 Combination Therapy in Autoimmune Diabetes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e5%b0%8f%e5%85%90%e6%9c%9f%e3%81%aesga%e5%85%90%e3%81%ae%e6%88%90%e9%95%b7%e3%83%9b%e3%83%ab%e3%83%a2%e3%83%b3%e6%b2%bb%e7%99%82%e3%81%af%e3%80%81%e8%82%a5%e6%ba%80%e5%85%90%e3%81%a8%e5%90%8c/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-19T14:18:46-07:00</news:publication_date><news:title>小児期のSGA児の成長ホルモン治療は、肥満児と同様にグルコース-インスリン代謝が障害される</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/tre-sinh-ra-voi-can-nang-thap-hon-tuoi-thai-duoc-dieu-tri-bang-hormone-tang-truong-co-su-roi-loan-chuyen-hoa-glucose-insulin-tuong-tu-nhu-tre-beo-phi/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-19T14:17:09-07:00</news:publication_date><news:title>Trẻ sinh ra với cân nặng thấp hơn tuổi thai được điều trị bằng hormone tăng trưởng có sự rối loạn chuyển hóa glucose-insulin tương tự như trẻ béo phì</news:title></news:news></url>
<url><loc>https://news.medxy.ai/children-born-sga-receiving-growth-hormone-have-similarly-impaired-glucose-insulin-metabolism-as-children-with-obesity/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-19T14:15:16-07:00</news:publication_date><news:title>Children Born SGA Receiving Growth Hormone Have Similarly Impaired Glucose-Insulin Metabolism as Children With Obesity</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e8%a1%80%e6%b6%b2%e4%b8%admtdna%e3%82%b3%e3%83%94%e3%83%bc%e6%95%b0%e3%81%a82%e5%9e%8b%e7%b3%96%e5%b0%bf%e7%97%85%e3%81%ae%e3%83%aa%e3%82%b9%e3%82%af%e3%81%a8%e3%81%aeu%e5%ad%97%e5%9e%8b%e9%96%a2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-19T12:26:37-07:00</news:publication_date><news:title>血液中mtDNAコピー数と2型糖尿病のリスクとのU字型関連</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/su-lien-quan-dang-u-giua-so-ban-sao-mtdna-trong-mau-va-nguy-co-bi-benh-dai-thao-duong-loai-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-19T12:24:40-07:00</news:publication_date><news:title>Sự Liên Quan Dạng U Giữa Số Bản Sao mtDNA Trong Máu và Nguy Cơ Bị Bệnh Đái Tháo Đường Loại 2</news:title></news:news></url>
<url><loc>https://news.medxy.ai/a-u-shaped-association-between-blood-mtdna-copy-number-and-risk-of-type-2-diabetes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-19T12:22:12-07:00</news:publication_date><news:title>A U-Shaped Association Between Blood mtDNA Copy Number and Risk of Type 2 Diabetes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/cardiogenic-shock-care-still-varies-widely-across-cicus-especially-in-the-choice-of-inodilators/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-19T12:01:30-07:00</news:publication_date><news:title>Cardiogenic Shock Care Still Varies Widely Across CICUs, Especially in the Choice of Inodilators</news:title></news:news></url>
<url><loc>https://news.medxy.ai/validated-emperor-preserved-risk-models-stratify-prognosis-in-finearts-hf-while-finerenone-benefits-remain-consistent-across-baseline-risk/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-19T11:59:12-07:00</news:publication_date><news:title>Validated EMPEROR-Preserved Risk Models Stratify Prognosis in FINEARTS-HF, While Finerenone Benefits Remain Consistent Across Baseline Risk</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e5%bf%83%e4%b8%8d%e5%85%a8%e3%81%ae%e5%b0%84%e8%a1%80%e5%88%86%e6%95%b0%e3%81%8c%e4%bd%8e%e4%b8%8b%e3%80%81%e8%bb%bd%e5%ba%a6%e4%bd%8e%e4%b8%8b%e3%80%81%e3%81%be%e3%81%9f%e3%81%af%e6%ad%a3%e5%b8%b8/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-19T11:58:09-07:00</news:publication_date><news:title>心不全の射血分数が低下、軽度低下、または正常のアウトカム：ESC HF III レジストリ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/ket-qua-cua-suy-tim-voi-phan-suat-tong-mau-giam-giam-nhe-hoac-bao-ton-dang-ky-esc-hf-iii/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-19T11:56:49-07:00</news:publication_date><news:title>Kết quả của suy tim với phân suất tống máu giảm, giảm nhẹ hoặc bảo tồn: Đăng ký ESC HF III</news:title></news:news></url>
<url><loc>https://news.medxy.ai/outcomes-of-heart-failure-with-reduced-mildly-reduced-or-preserved-ejection-fraction-esc-hf-iii-registry/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-19T11:54:22-07:00</news:publication_date><news:title>Outcomes of Heart Failure With Reduced, Mildly Reduced, or Preserved Ejection Fraction: ESC HF III Registry</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e5%a4%9a%e5%8b%95%e8%84%88%e3%83%90%e3%82%a4%e3%83%91%e3%82%b9%e3%81%a8%e5%86%a0%e5%8b%95%e8%84%88%e3%83%90%e3%82%a4%e3%83%91%e3%82%b9%e8%a1%93%e5%be%8c%e3%81%ae%e7%94%9f%e5%ad%98%e7%8e%87-%e5%99%a8/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-19T11:44:28-07:00</news:publication_date><news:title>多動脈バイパスと冠動脈バイパス術後の生存率: 器具変数分析</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/cay-ghep-da-dong-mach-va-su-song-sot-sau-cay-ghep-dong-mach-vanh-phan-tich-bien-so-cong-cu/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-19T11:42:33-07:00</news:publication_date><news:title>Cấy ghép đa động mạch và sự sống sót sau cấy ghép động mạch vành: Phân tích biến số công cụ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/multiarterial-grafting-and-survival-after-coronary-artery-bypass-grafting-an-instrumental-variable-analysis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-19T11:40:06-07:00</news:publication_date><news:title>Multiarterial Grafting and Survival After Coronary Artery Bypass Grafting: An Instrumental Variable Analysis</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e4%bb%a5%e5%89%8d%e3%81%ae%e7%b5%8c%e7%9a%ae%e7%9a%84%e5%86%a0%e5%8b%95%e8%84%88%e4%bb%8b%e5%85%a5%e6%b2%bb%e7%99%82%e3%82%92%e5%8f%97%e3%81%91%e3%81%9f%e3%81%8c%e5%bf%83%e7%ad%8b%e6%a2%97%e5%a1%9e/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-19T11:25:53-07:00</news:publication_date><news:title>以前の経皮的冠動脈介入治療を受けたが心筋梗塞の既往がない患者におけるエボロクマブ：VESALIUS-CV試験の結果</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/evolocumab-o-benh-nhan-da-thuc-hien-can-thiep-dong-mach-vanh-qua-da-va-chua-tung-co-nhoi-mau-co-tim-ket-qua-tu-thu-nghiem-vesalius-cv/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-19T11:24:14-07:00</news:publication_date><news:title>Evolocumab ở Bệnh Nhân Đã Thực Hiện Can thiệp Động mạch vành qua Da và Chưa Từng Có Nhồi máu cơ tim: Kết quả từ Thử nghiệm VESALIUS-CV</news:title></news:news></url>
<url><loc>https://news.medxy.ai/evolocumab-in-patients-with-prior-percutaneous-coronary-intervention-and-no-prior-mi-results-from-the-vesalius-cv-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-19T11:22:06-07:00</news:publication_date><news:title>Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/%e6%9c%af%e5%89%8d%e6%94%be%e7%96%97%e5%89%82%e9%87%8f%e5%87%8f%e5%b0%91%e8%87%b336-gy%e5%9c%a8%e9%bb%8f%e6%b6%b2%e6%80%a7%e8%84%82%e8%82%aa%e8%82%89%e7%98%a4%e4%b8%ad%e7%bb%b4%e6%8c%81%e9%95%bf/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-05-19T11:19:44-07:00</news:publication_date><news:title>术前放疗剂量减少至36 Gy在黏液性脂肪肉瘤中维持长期局部控制</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e8%a1%93%e5%89%8d%e6%94%be%e5%b0%84%e7%b7%9a%e7%99%82%e6%b3%95%e3%82%9236-gy%e3%81%ab%e5%89%8a%e6%b8%9b%e3%81%97%e3%81%a6%e3%82%82%e7%b2%98%e6%b6%b2%e6%80%a7%e8%84%82%e8%82%aa%e8%82%89%e8%85%ab/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-19T11:17:50-07:00</news:publication_date><news:title>術前放射線療法を36 Gyに削減しても粘液性脂肪肉腫の長期局所制御は良好を維持</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/giam-lieu-xa-tri-tien-phau-thuat-xuong-36-gy-duy-tri-kiem-soat-cuc-bo-dai-han-xuat-sac-trong-liposarcoma-nhay/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-19T11:14:40-07:00</news:publication_date><news:title>Giảm liều xạ trị tiền phẫu thuật xuống 36 Gy duy trì kiểm soát cục bộ dài hạn xuất sắc trong liposarcoma nhầy</news:title></news:news></url>
<url><loc>https://news.medxy.ai/reduced-preoperative-radiotherapy-to-36-gy-maintains-excellent-long-term-local-control-in-myxoid-liposarcoma/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-19T11:10:43-07:00</news:publication_date><news:title>Reduced Preoperative Radiotherapy to 36 Gy Maintains Excellent Long-Term Local Control in Myxoid Liposarcoma</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/%e9%9b%a3%e6%b2%bb%e6%80%a7%e5%a4%a7%e3%81%86%e3%81%a4%e7%97%85%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e3%82%b7%e3%83%ad%e3%82%b7%e3%83%93%e3%83%b3%e3%81%ae%e6%9c%89%e5%8a%b9%e6%80%a7%e3%81%a8%e5%ae%89/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-05-19T00:22:53-07:00</news:publication_date><news:title>難治性大うつ病におけるシロシビンの有効性と安全性: EPISODE ランダム化比較試験</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/hieu-qua-va-an-toan-cua-psilocybin-trong-dieu-tri-tram-cam-trong-muc-khang-tri-thu-nghiem-lam-sang-ngau-nhien-episode/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-05-19T00:20:51-07:00</news:publication_date><news:title>Hiệu quả và An toàn của Psilocybin trong Điều trị Trầm cảm Trọng mức Kháng trị: Thử nghiệm lâm sàng ngẫu nhiên EPISODE</news:title></news:news></url>
<url><loc>https://news.medxy.ai/efficacy-and-safety-of-psilocybin-in-treatment-resistant-major-depression-the-episode-randomized-clinical-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-19T00:18:11-07:00</news:publication_date><news:title>Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial</news:title></news:news></url>
</urlset>
